AB Enzymes and AB Vista, both subsidiaries of Associated British Foods (ABF) plc, have announced the acquisition of Syngenta’s Quantum Phytase feed enzyme business and technology.
AB Enzymes will take over responsibility for the Quantum
supply chain and further product development, whilst AB Vista will manage
Quantum sales & marketing. Quantum Phytase is a unique enzyme with superior
thermo-tolerance and efficacy, which will compliment the existing range of feed
enzymes that AB Vista currently markets. Quantum sales are growing strongly in
Latin America and market penetration is expected to increase further when
product registrations in other major markets are completed.
Aryan Moelker, CEO AB Enzymes, said
“the addition of this unique new enzyme is exciting in that it broadens our
technology base and enhances our market reach. We are now well placed to meet
the increasing global demand for heat stable phytases. The joint goal of our
partnership with
AB Vista is to build market leading positions in key feed
enzyme segments. This acquisition significantly increases our opportunity to
reach this goal.”
Related websites:
Associated British
Foods
Syngenta